body contouring

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Payward’s Bitnomial acquisition shows Kraken is building infrastructure, not just buying growth

Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal

Badger Meter (BMI) adds UK sewer monitoring platform UDlive in $100m expansion move

Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?

Venus Concept secures FDA 510(k) clearance for Venus NOVA, its next-gen platform redefining non-invasive aesthetics

Find out how Venus Concept’s FDA clearance for Venus NOVA could transform non-invasive body and skin treatments while testing investor confidence in the company’s turnaround.

bySoujanya Ravi

November 10, 2025

AirSculpt Technologies expands to Columbus: New center elevates body contouring experience

AirSculpt Technologies, Inc. (NASDAQ: AIRS), renowned for its premium body contouring services, has expanded its footprint with the…

byPallavi Madhiraju

August 20, 2024

The Latest

Payward’s Bitnomial acquisition shows Kraken is building infrastructure, not just buying growth

Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal

Badger Meter (BMI) adds UK sewer monitoring platform UDlive in $100m expansion move

Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?

Venus Concept secures FDA 510(k) clearance for Venus NOVA, its next-gen platform redefining non-invasive aesthetics

AirSculpt Technologies expands to Columbus: New center elevates body contouring experience

Payward’s Bitnomial acquisition shows Kraken is building infrastructure, not just buying growth

Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal

Badger Meter (BMI) adds UK sewer monitoring platform UDlive in $100m expansion move

Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?

What Alamar Biosciences’ (NASDAQ: ALMR) IPO pop says about the next phase of proteomics investing

UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control

Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention

Iran reverses Hormuz opening within 24 hours — IRGC fires on tankers as blockade standoff deepens